NSE: VINATIORGA | BSE: 524200

Mid-range Performer

Download real time

1902.50 17.30 (0.92%)

34.69% Gain from 52W Low

50,642 NSE+BSE Volume

NSE 20 Jun, 2025 3:45 PM (IST)

19,722.4

Market Cap

High in industry

0.7

Beta 1Year

Very Low volatility

Vinati Organics Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for VINATIORGA, BSE:524200 Vinati Organics Ltd.

Vinati Organics Ltd.

19 Aug 2024, 12:00AM

1902.50

0.92%

Weak Q1; expect gradual recovery in H2

Hold: Vinati Organics Ltd.

Recommendation Target

Sharekhan

Q1 PAT of Rs. 86 crore, which is an 18% decline q-o-q, fell 22% short of our estimate due to weaker-than-expected revenue and higher raw material costs.

Vinati Organics Ltd. has an average target of 2052.50 from 6 brokers.

Vinati Organics Ltd.

12 Aug 2024

1902.50

0.92%

Subdued performance but confident of regaining momentum

Buy: Vinati Organics Ltd.

Target

Motilal Oswal

Vinati Organics (VO)’s 1QFY25 revenue came in below our estimate at INR5.2b. Gross margin declined 270bp YoY to 44.9%, while EBITDAM was up 100bp YoY at 23.8%.

Vinati Organics Ltd. has an average target of 2052.50 from 6 brokers.

Vinati Organics Ltd.

12 Aug 2024

1902.50

0.92%

VINATI ORGANICS LTD.

Accumulate: Vinati Organics Ltd.

Target

Prabhudas Lilladhar

Vinati Organics Ltd. is trading above all available SMAs

Vinati Organics Ltd.

12 Aug 2024

1902.50

0.92%

Vinati Organics | Q1FY25 Result Update

Buy: Vinati Organics Ltd.

Target

Edelweiss

In-line performance in Q1; outlook remains healthy

Vinati Organics Ltd. is trading above all available SMAs

Vinati Organics Ltd.

31 May 2024

1902.50

0.92%

Improved top-line and profitability growth amidst recovery in demand

Hold: Vinati Organics Ltd.

Recommendation Target

KRChoksey

VO announced revenue of INR 5,503 Mn (+22.8% QoQ/+6.0% YoY) surpassing our estimates driven by the normalization of ATBS sales, as destocking is now concluded.
EBITDA grew to INR 1,499 Mn (+30.8% QoQ/+1.8% YoY) beating our estimates on back of strong top-line growth, lower power and fuel expense, and lower other expenses with EBITDA margins at 27.2% (+165 bps/ -111 bps).

Vinati Organics Ltd. is trading above all available SMAs

Vinati Organics Ltd.

20 May 2024, 12:00AM

1902.50

0.92%

Vinati Organics | Q4FY24 Result Update

Buy: Vinati Organics Ltd.

Edelweiss

Sequential recovery in Q4; a healthy growth to sustain

Vinati Organics Ltd. has an average target of 2052.50 from 6 brokers.

Vinati Organics Ltd.

19 May 2024, 12:00AM

1902.50

0.92%

Volume recovery leads to a robust performance

Buy: Vinati Organics Ltd.

Target

Motilal Oswal

Vinati Organics (VO)’s revenue came above our estimate due to a robust
recovery in volumes across products in 4QFY24. However, gross margin
contracted 310bp YoY to 46.6%, while EBITDAM was down 110bp YoY to 27.3%.
EBITDA rose 2% YoY to INR1.5b, while PAT was flat at INR1b (our est. INR630m).

Vinati Organics Ltd. is trading above all available SMAs

Vinati Organics Ltd.

14 Mar 2024

1902.50

0.92%

VINATI ORGANICS

Accumulate: Vinati Organics Ltd.

Recommendation Target

Geojit BNP Paribas

Vinati Organics Ltd. has an average target of 2052.50 from 6 brokers.

Vinati Organics Ltd.

05 Mar 2024

1902.50

0.92%

VINATI ORGANICS LTD.

Hold: Vinati Organics Ltd.

Target

Prabhudas Lilladhar

Vinati Organics Ltd. is trading above all available SMAs

Vinati Organics Ltd.

16 Feb 2024

1902.50

0.92%

Weak performance may signal longer road to recovery

Buy: Vinati Organics Ltd.

Recommendation Target

KRChoksey

The Company's Q3FY24 performance was marked by a 13.3% YoY and 3.2% QoQ decline in revenue, primarily due to destocking in ATBS (65% market share, capacity of 40,000 tonnes) and broader pricing pressures across its portfolio. ATBS, contributing roughly 30% of revenue, witnessed price corrections to USD 3.2 amidst rising raw material costs (RMC) and freight expenses.

Vinati Organics Ltd. is trading above all available SMAs

Is Vinati Organics Ltd. worth buying?

906 Votes:

Buy 91.06%

Sell 5.63%

Hold 3.31%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf